E-LIB Suche - Ergebnisse für: John W. Ostrominski

1

Heart failure with preserved ejection fraction therapy: com..:

Ostrominski, John W ; Solomon, Scott D ; Vaduganathan, Muthiah
European Heart Journal. 45 (2024) 30 - p. 2748-2751 , 2024

Link: https://doi.org/10.1093/..

2

Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure ..:

Ostrominski, John W. ; Vaduganathan, Muthiah
Journal of Cardiac Failure. , 2024

Link: https://doi.org/10.1016/..

3

Cardiovascular-Kidney-Metabolic Overlap in Heart Failure Wi..:

Ostrominski, John W. ; Claggett, Brian L. ; Miao, Zi Michael...
Journal of the American College of Cardiology. 84 (2024) 2 - p. 223-228 , 2024

Link: https://doi.org/10.1016/..

4

Effect of dapagliflozin in patients with diabetes and heart..:

Lassen, Mats Christian Højbjerg ; Ostrominski, John W. ; Inzucchi, Silvio E....
European Journal of Heart Failure. 26 (2024) 7 - p. 1539-1548 , 2024

Link: https://doi.org/10.1002/..

5

Forecasting cardiovascular risk reduction with semaglutide ..:

Lassen, Mats C Højbjerg ; Skaarup, Kristoffer Grundtvig ; Vaduganathan, Muthiah...
European Journal of Preventive Cardiology. , 2024

Link: https://doi.org/10.1093/..

6

Qualitative evaluation of artificial intelligence-generated..:

Kim, Dong Wook ; Park, Ji Seok ; Sharma, Kavita...
Frontiers in Nutrition. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

7

Generalizability of the Spectrum of Kidney Risk in the FINE..:

OSTROMINSKI, JOHN W. ; AGGARWAL, RAHUL ; CLAGGETT, BRIAN L....
Journal of Cardiac Failure. , 2024

Link: https://doi.org/10.1016/..

8

Cardiovascular‐kidney‐metabolic overlap in heart failure wi..:

Lassen, Mats C.H. ; Ostrominski, John W. ; Claggett, Brian L....
European Journal of Heart Failure. , 2024

Link: https://doi.org/10.1002/..

9

STEPping down diuretic therapy with semaglutide in obesity-..:

Ostrominski, John W ; Chatur, Safia ; Vaduganathan, Muthiah
European Heart Journal. , 2024

Link: https://doi.org/10.1093/..

10

Chapter 2: Clinical and Mechanistic Potential of Sodium-Glu..:

Ostrominski, John W. ; Vaduganathan, Muthiah
The American Journal of Medicine. 137 (2024) 2 - p. S9-S24 , 2024

Link: https://doi.org/10.1016/..

11

Baseline characteristics of patients with heart failure wit..:

Solomon, Scott D. ; Ostrominski, John W. ; Vaduganathan, Muthiah...
European Journal of Heart Failure. 26 (2024) 6 - p. 1334-1346 , 2024

Link: https://doi.org/10.1002/..

12

Risk Stratification and Treatment of Obesity for Primary an..:

Ostrominski, John W. ; Powell-Wiley, Tiffany M.
Current Atherosclerosis Reports. 26 (2023) 1 - p. 11-23 , 2023

Link: https://doi.org/10.1007/..

13

Defining the optimal approach to revascularization in chron..:

Ostrominski, John W. ; Boden, William E.
IJC Heart & Vasculature. 46 (2023) - p. 101200 , 2023

Link: https://doi.org/10.1016/..

14

Duration of Heart Failure with Preserved Ejection Fraction ..:

Ostrominski, John W. ; Claggett, Brian L. ; Packer, Milton...
Journal of Cardiac Failure. , 2023

Link: https://doi.org/10.1016/..

15

Cardiac Myosin Inhibitors for Managing Obstructive Hypertro..:

Ostrominski, John W. ; Guo, Ruby ; Elliott, Perry M..
JACC: Heart Failure. 11 (2023) 7 - p. 735-748 , 2023

Link: https://doi.org/10.1016/..